Circulating Vitamin D May Lower Risk of Metastatic Progression

Acredit’s Hanna Abrahamsson has published a paper showing that high-risk rectal cancer patients with higher levels of circulating vitamin D do better overall during treatment than similar patients with lower levels of vitamin D. Hanna’s study indicates that vitamin D may play a role in positively affecting the outcome of treatment given to patients presenting with later stage cancers, potentially improving chances of survival. Further research is required to show whether supplementation with vitamin D will assist with increasing overall survival rates in all patients, but this finding is very exciting nonetheless.

Read more about vitamin D in liver metastasis from rectal cancer here.